Clinicopathological Significance of Stromal Myofibroblasts in Invasive Ductal Carcinoma of the Breast

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Tumor Biology

• Publication date

  2004-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000081394PMID 15627894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: Anin situ hybridization and immunohistochemistry study

  2005cited by this paper
• CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx.

  2004cited by this paper
• CD34+ fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx

  2004cited by this paper
• Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment.

  2003cited by this paper
• The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.

  2003cited by this paper
• CD34+ fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri

  2002cited by this paper
• CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions

  2002cited by this paper
• Human fibroblasts from normal and malignant breast tissue grown in vitro show a distinct senescence profile and telomerase activity

  2002cited by this paper
• The complexities of breast cancer desmoplasia

  2001cited by this paper
• Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast.

  2000cited by this paper
• Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma

  2000cited by this paper
• Local feedback mechanisms in human breast cancer

  2000cited by this paper
• Urokinase-type-plasminogen-activator (uPA) production by human breast (myo) fibroblasts in vitro: influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cells.

  1998cited by this paper
• Observations on the role of FXIIIa+ dendritic mammary stromal cells in myofibroblastic stromal remodeling and angiogenesis in mammary carcinoma.

  1998cited by this paper
• Urokinase‐type‐plasminogen‐activator(UPA) production by human breast (myo)fibroblasts in vitro: Influence of transforming growth factor‐β1 (TGFβ1) compared with factor(s) released by human epithelial‐carcinoma cells

  1998cited by this paper
• Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.

  1997cited by this paper
• Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family.

  1996cited by this paper
• Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer : Paracrine regulation by carcinoma cell-derived members of the transforming growth factor β family

  1996cited by this paper
• Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function.

  1995cited by this paper
• Tumor-stroma interactions and stromal cell density regulate hepatocyte growth factor protein levels: a role for transforming growth factor-beta activation.

  1995cited by this paper
• Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression.

  1994cited by this paper

• Characterization of gastric cancer-stimulated signaling pathways and function of CTGF in cancer-associated fibroblasts

  2024cites this paper
• FGFR-related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)

  2024cites this paper
• Fibroblast Growth Factor-2 and the Invasive Potential in Urothelial Malignancies of the Bladder

  2023cites this paper
• Reassessing Breast Cancer-Associated Fibroblasts (CAFs) Interactions with Other Stromal Components and Clinico-Pathologic Parameters by Using Immunohistochemistry and Digital Image Analysis (DIA)

  2023cites this paper
• Alterations in the Mammary Gland and Tumor Microenvironment of Formerly Obese Mice

  2023cites this paper
• Hematopoietic Transcription Factor RUNX1 is Essential for Promoting Macrophage–Myofibroblast Transition in Non‐Small‐Cell Lung Carcinoma

  2023cites this paper
• Alterations in the mammary gland and tumor microenvironment of formerly obese mice

  2023cites this paper
• Brain metastasis-associated fibroblasts secrete fucosylated PVR/CD155 that induces breast cancer invasion.

  2023cites this paper
• An agarose-alginate microfluidic device for the study of spheroid invasion, ATRA inhibits CAFs-mediated matrix remodeling

  2023cites this paper
• MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment

  2022cites this paper
• Nanomodulation and nanotherapeutics of tumor-microenvironment

  2022cites this paper
• Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer

  2022cites this paper
• Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts

  2021cites this paper
• CD34 EXPRESSION AS A SURROGATE MARKER FOR DIAGNOSIS OF INVASIVE DUCTAL CARCINOMA OF BREAST.

  2021cites this paper
• MSC-Derived Extracellular Vesicles in Tumors and Therapy

  2021cites this paper
• Tumor elastography and its association with cell-free tumor DNA in the plasma of breast tumor patients: a pilot study.

  2021cites this paper
• PYCR1-dependent proline synthesis in cancer-associated fibroblasts is required for the deposition of pro-tumorigenic extracellular matrix

  2020cites this paper
• Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions

  2020cites this paper
• A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer

  2020cites this paper
• Combination diagnosis with elastography strain ratio and molecular markers effectively improves the diagnosis rate of small breast cancer and lymph node metastasis.

  2020cites this paper
• Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors

  2019cites this paper
• Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy

  2017cites this paper
• A Clinicopathological Study of cd34 Antigen Expression in Benign and Malignant Breast Lesions

  2017cites this paper
• RETRACTED ARTICLE: Modulation of the TGF-β1-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells

  2017cites this paper
• α-Smooth muscle actin expression in cancerassociated fibroblasts in canine epithelial tumors

  2017cites this paper
• Methanolic Leaf Extract of Diospyros chloroxylon Modulates Hepatic Redox Profile and Cell Proliferation in Dimethylamine-treated Rats

  2017cites this paper
• CD-10: An Emerging biomarker in Prognostication of Infiltrating Duct Carcinoma Breast

  2016cites this paper
• CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients

  2016cites this paper
• The role of cancer-associated fibroblasts in breast cancer pathobiology.

  2016cites this paper
• Mesenchymal Stem Cells During Tumor Formation and Dissemination

  2016cites this paper
• Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go

  2016cites this paper
• Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions.

  2016cites this paper
• Inflammatory fibroblasts in cancer

  2016cites this paper
• CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients

  2015cites this paper
• Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-β1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity.

  2015cites this paper
• Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression.

  2015cites this paper
• Metabolic reprogramming in gastric cancer

  2015cites this paper
• E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling

  2014cites this paper
• G protein-coupled estrogen receptor regulation of migration and metastasis in the breast

  2014influential citation
• Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer

  2014cites this paper
• Consideration of the cellular microenvironment: physiologically relevant co-culture systems in drug discovery.

  2014cites this paper
• CD34+ stromal cells/fibroblasts/fibrocytes/telocytes as a tissue reserve and a principal source of mesenchymal cells. Location, morphology, function and role in pathology.

  2014cites this paper
• Differentiation of mesenchymal stem cells from the adipose tissue into carcinoma-associated myofibroblasts in interaction with human breast cancer cells

  2014cites this paper
• Triggering the landslide: The tumor-promotional effects of myofibroblasts.

  2013cites this paper
• Exploiting the chick embryonic environment to reprogram neuroblastoma cells to a benign phenotype

  2013cites this paper
• Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β‐catenin in histological grading and clinical outcome

  2013cites this paper
• Comparing the expression of myoepithelial cell markers CD10 and smooth muscle actin with the estrogen receptor status in the invasive carcinoma breast: An immunohistochemical study

  2013cites this paper
• Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast

  2013cites this paper
• Glucose Metabolism in Cancer-Associated Fibroblasts

  2013cites this paper
• In Vitro Evidence of the Presence of Mesenchymal Stromal Cells in Cervical Cancer and Their Role in Protecting Cancer Cells from Cytotoxic T Cell Activity

  2013cites this paper
• Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis.

  2012cites this paper
• Chemotherapeutic Targeting of Fibulin-5 to Suppress Breast Cancer Invasion and Metastasis Stimulated by Transforming Growth Factor-Beta

  2012cites this paper
• ER-activating ability of breast cancer stromal fibroblasts is regulated independently of alteration of TP53 and PTEN tumor suppressor genes.

  2012cites this paper
• Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome

  2012cites this paper
• Mesenchymal stem cells in tumor development

  2012cites this paper
• Comparison of Myofibroblasts Expression in Oral Squamous Cell Carcinoma, Verrucous Carcinoma, High Risk Epithelial Dysplasia, Low Risk Epithelial Dysplasia and Normal Oral Mucosa

  2012cites this paper
• Hyaluronan: A Key Microenvironmental Mediator of Tumor-Stromal Cell Interactions

  2011cites this paper
• Inflammatory Alterations of the Extracellular Matrix in the Tumor Microenvironment

  2011cites this paper
• Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma

  2011cites this paper
• Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors

  2011cites this paper
• Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression

  2011cites this paper
• Increased Presence of Stromal Myofibroblasts and Tenascin-C With Malignant Progression in Canine Mammary Tumors

  2011cites this paper
• Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer.

  2011cites this paper
• Appearance and distribution of stromal myofibroblasts and tenascin-C in feline mammary tumors.

  2011cites this paper
• Bone Marrow Derived Mesenchymal Stem/Stromal Cells and Tumor Growth

  2010cites this paper
• EVALUATION THE αSMA POSITIVE MYOFIBROBLASTS IN ORAL SQUAMOUS CELL CARCINOMA AND ORAL EPITHELIAL DYSPLASIA AND HYPERKERATOSIS

  2010cites this paper
• Tight junction proteins and cancer-associated fibroblasts in ameloblastoma, ameloblastic carcinoma and mobile tongue cancer

  2010cites this paper
• Fibrocytes (Reactive or Reparative)

  2010cites this paper
• Aberrant Signaling Pathways in Pancreatic Cancer

  2010cites this paper
• OPTIMIZATION AND VALIDATION OF A SPECIES- SPECIFIC IN VIVO APPROACH FOR STUDIES ON GROWTH AND PROGRESSION OF NEURAL CREST DERIVED TUMOURS

  2010cites this paper
• Myofibroblast stromal presence and distribution in squamous epithelial carcinomas, oral dysplasia and hyperkeratosis.

  2010cites this paper
• The Pathophysiology of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β in Normal and Malignant Mammary Epithelial Cells

  2010cites this paper
• Adipose Tissue-Derived Stem Cells Differentiate into Carcinoma-Associated Fibroblast-Like Cells under the Influence of Tumor-Derived Factors

  2010cites this paper
• Mechanisms of Epithelial-Mesenchymal Transition by TGF- β

  2010cites this paper
• Oxidative stress promotes myofibroblast differentiation and tumour spreading

  2010cites this paper
• Mechanisms of the epithelial-mesenchymal transition by TGF-beta.

  2009cites this paper
• Presence Of Cancer-Associated Fibroblasts Inversely Correlates With Schwannian Stroma In Neuroblastoma Tumors

  2009cites this paper
• The role of a human hematopoietic mesenchymal progenitor in wound healing and fibrotic diseases and implications for therapy.

  2009cites this paper
• Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression

  2009cites this paper
• CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer.

  2009cites this paper
• The recruitment of stromal cells to the site of tumor formation

  2009cites this paper
• The role of the tumor microenvironment in the progression of pancreatic cancer.

  2008cites this paper
• Reactive Stroma and Evolution of Tumors: Integration of Transforming Growth Factor-β, Connective Tissue Growth Factor, and Fibroblast Growth Factor-2 Activities

  2008cites this paper
• Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner.

  2008cites this paper
• SPARC enhances tumor stroma formation and prevents fibroblast activation

  2007cites this paper
• Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor.

  2007cites this paper
• The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses

  2007cites this paper
• CD34+ fibrocytes are preserved in most invasive lobular carcinomas of the breast.

  2007cites this paper
• Dynamic stromal‐epithelial interactions during progression of MCF10DCIS.com xenografts

  2007cites this paper
• The role of the stroma in carcinogenesis.

  2006cites this paper
• Molecular aspects of stromal-parenchymal interactions in malignant neoplasms.

  2006cites this paper
• Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers.

  2006cites this paper
• Gene expression perturbation in vitro--a growing case for three-dimensional (3D) culture systems.

  2005cites this paper
• Epithelial to Mesenchymal Transition Tumors: Fallacious or Snail's Pace?

  2005cites this paper
• Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.

  2005cites this paper
• Tumores Mamários da Cadela Estudo de Factores Biológicos (Ciclooxigenases 1 e 2; Prolactina; Hormona do Crescimento; Factor I de Crescimento Tipo Insulina) e da sua Implicação Clínica e Prognóstica

  2005cites this paper